Figure 5.
Compiled plots of patients with and without GVHD. The data obtained on the samples collected over the observation period were compiled for the patients without complications after HSCT (w/o GVHD) and compared with the polypeptide patterns obtained from patients at diagnosis of GVHD (w/GVHD). Comparison of the 2 patterns shows a number of differentially excreted polypeptides, as visualized here by inserts that magnify the particular parts of the pattern were the changes occur (marked by arrows). Shown are 4 discriminatory peptides, marked in each pattern with A to D and arrows indicating the position of each of these molecules in the compiled patterns, for patients without (w/o) or with (w/) GVHD. Panels A and C show polypeptides newly appearing in all patients with GVHD. Panel B shows a more than 10-fold increase in signal intensity observed in all samples of patients with GVHD, while panel D shows a more than 10-fold reduction of the intensity of the 3.44 kDa/44.1 minutes peptide.